These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 35371063)

  • 1. Venous Air Embolism Activates Complement C3 Without Corresponding C5 Activation and Trigger Thromboinflammation in Pigs.
    Storm BS; Ludviksen JK; Christiansen D; Fure H; Pettersen K; Landsem A; Nilsen BA; Dybwik K; Braaten T; Nielsen EW; Mollnes TE
    Front Immunol; 2022; 13():839632. PubMed ID: 35371063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Air Bubbles Activate Complement and Trigger Hemostasis and C3-Dependent Cytokine Release Ex Vivo in Human Whole Blood.
    Storm BS; Christiansen D; Fure H; Ludviksen JK; Lau C; Lambris JD; Woodruff TM; Brekke OL; Braaten T; Nielsen EW; Mollnes TE
    J Immunol; 2021 Dec; 207(11):2828-2840. PubMed ID: 34732467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Femoral nailing associated with bone marrow emboli in pigs induced a specific increase in blood IL-6 and broad inflammatory responses in the heart and lungs.
    Kristiansen S; Storm BS; Emblem ÅE; Grønli RH; Pettersen K; Hilmo J; Jarmund AH; Leth-Olsen M; Nyrnes SA; Nilsen BA; Nielsen EW; Mollnes TE
    Front Immunol; 2024; 15():1396800. PubMed ID: 39100680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thromboinflammatory response is increased in pancreas transplant alone versus simultaneous pancreas-kidney transplantation and early pancreas graft thrombosis is associated with complement activation.
    Rydenfelt K; Kjøsen G; Horneland R; Ludviksen JK; Jenssen TG; Line PD; Tønnessen TI; Mollnes TE; Haugaa H; Pischke SE
    Front Immunol; 2023; 14():1044444. PubMed ID: 37063904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of the C3 inhibitor compstatin in a human whole blood model designed for complement research - 20 years of experience and future perspectives.
    Mollnes TE; Storm BS; Brekke OL; Nilsson PH; Lambris JD
    Semin Immunol; 2022 Jan; 59():101604. PubMed ID: 35570131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement C3 cleavage and cytokines interleukin-1beta and tumor necrosis factor-alpha in otitis media with effusion.
    Närkiö-Mäkelä M; Teppo AM; Meri S
    Laryngoscope; 2000 Oct; 110(10 Pt 1):1745-9. PubMed ID: 11037838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement Component C5 and TLR Molecule CD14 Mediate Heme-Induced Thromboinflammation in Human Blood.
    Thomas AM; Gerogianni A; McAdam MB; Fløisand Y; Lau C; Espevik T; Nilsson PH; Mollnes TE; Barratt-Due A
    J Immunol; 2019 Sep; 203(6):1571-1578. PubMed ID: 31413105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement Activation in Arterial and Venous Thrombosis is Mediated by Plasmin.
    Foley JH; Walton BL; Aleman MM; O'Byrne AM; Lei V; Harrasser M; Foley KA; Wolberg AS; Conway EM
    EBioMedicine; 2016 Mar; 5():175-82. PubMed ID: 27077125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human skin mast cells express complement factors C3 and C5.
    Fukuoka Y; Hite MR; Dellinger AL; Schwartz LB
    J Immunol; 2013 Aug; 191(4):1827-34. PubMed ID: 23833239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous C5 and CD14 inhibition limits inflammation and organ dysfunction in pig polytrauma.
    Lupu L; Horst K; Greven J; Mert Ü; Ludviksen JAK; Pettersen K; Lau C; Li Y; Palmer A; Qin K; Zhang X; Mayer B; van Griensven M; Huber-Lang M; Hildebrand F; Mollnes TE
    Front Immunol; 2022; 13():952267. PubMed ID: 36059503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic Oligodeoxynucleotide CpG Motifs Activate Human Complement through Their Backbone Structure and Induce Complement-Dependent Cytokine Release.
    de Boer E; Sokolova M; Quach HQ; McAdam KE; Götz MP; Chaban V; Vaage J; Fageräng B; Woodruff TM; Garred P; Nilsson PH; Mollnes TE; Pischke SE
    J Immunol; 2022 Nov; 209(9):1760-1767. PubMed ID: 36104112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Avoiding ambient air in test tubes during incubations of human whole-blood minimizes complement background activation.
    Storm BS; Christiansen D; Mollnes TE; Nielsen EW
    J Immunol Methods; 2020 Dec; 487():112876. PubMed ID: 33031792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of complement component C5 prevents clotting in an ex vivo model of xenogeneic activation of coagulation.
    Rataj D; Werwitzke S; Haarmeijer B; Winkler M; Ramackers W; Petersen B; Niemann H; Wünsch A; Bähr A; Klymiuk N; Wolf E; Abicht JM; Ayares D; Tiede A
    Xenotransplantation; 2016 Mar; 23(2):117-27. PubMed ID: 26773447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement activation in angiotensin II-induced organ damage.
    Shagdarsuren E; Wellner M; Braesen JH; Park JK; Fiebeler A; Henke N; Dechend R; Gratze P; Luft FC; Muller DN
    Circ Res; 2005 Sep; 97(7):716-24. PubMed ID: 16109917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo downregulation of C3 by lipoteichoic acid isolated from Lactobacillus plantarum K8 suppressed cytokine-mediated complement system activation.
    Jeon B; Kim HR; Kim H; Chung DK
    FEMS Microbiol Lett; 2016 Jul; 363(14):. PubMed ID: 27231239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement activation and release of tumour necrosis factor alpha, interleukin-2, interleukin-6 and soluble tumour necrosis factor and interleukin-2 receptors during and after cardiopulmonary bypass in children.
    Saatvedt K; Lindberg H; Geiran OR; Michelsen S; Aasen AO; Pedersen T; Mollnes TE
    Scand J Clin Lab Invest; 1995 Feb; 55(1):79-86. PubMed ID: 7624740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-1 alpha, interleukin 6 and tumor necrosis factor alpha increase the synthesis and expression of the functional alternative and terminal complement pathways by human umbilical vein endothelial cells in vitro.
    Berge V; Johnson E; Berge KE
    APMIS; 1996 Mar; 104(3):213-9. PubMed ID: 8611196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement C5 but not C3 is expendable for tissue factor activation by cofactor-independent antiphospholipid antibodies.
    Müller-Calleja N; Ritter S; Hollerbach A; Falter T; Lackner KJ; Ruf W
    Blood Adv; 2018 May; 2(9):979-986. PubMed ID: 29716893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperacute lung rejection in the pig-to-human model. 2. Synergy between soluble and membrane complement inhibition.
    Azimzadeh A; Zorn GL; Blair KS; Zhang JP; Pfeiffer S; Harrison RA; Cozzi E; White DJ; Pierson RN
    Xenotransplantation; 2003 Mar; 10(2):120-31. PubMed ID: 12588645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement inhibition can decrease the haemostatic response in a microvascular bleeding model at multiple levels.
    Golomingi M; Kohler J; Lamers C; Pouw RB; Ricklin D; Dobó J; Gál P; Pál G; Kiss B; Dopler A; Schmidt CQ; Hardy ET; Lam W; Schroeder V
    Front Immunol; 2023; 14():1226832. PubMed ID: 37771595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.